Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

Children's hair loss can be caused by many factors, including autoimmune diseases, emotional stress, genetics, and infections, with treatment and prognosis varying.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

A 12-year-old boy with twenty nail dystrophy, a condition affecting all nails, was treated conservatively due to its self-limiting nature and good prognosis.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

The document concludes that understanding nail anatomy is key for diagnosing nail diseases, early signs of nail melanoma may allow for less aggressive treatment, and specific genetic mutations are important in thyroid cancer prognosis and treatment.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

Some herbal therapies may help with skin conditions, but more research is needed to confirm their safety and effectiveness.

Deep phenotyping helps distinguish between xeroderma pigmentosum and trichothiodystrophy, aiding in diagnosis and treatment.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Personalized treatment plans improve vitiligo care.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

New method accurately measures finasteride in tablets.

New, cheaper method measures finasteride in tablets accurately and quickly.

The document concludes that injecting platelet-rich plasma can effectively treat androgenetic alopecia, a type of hair loss.

AMT may cause hair loss and changing dWAT activity could help treat it.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Model improves accuracy in predicting hair loss effects.

Computer-aided imaging system helps measure balding area in female pattern hair loss.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Too much epidermal growth factor can cause hair loss.

Hormones cause hair loss by affecting cell growth and weakening cell attraction.

The document suggests a new way to categorize skin and mind disorders into two main groups to reduce confusion.

New method, hair distribution width (HDW), improves accuracy in diagnosing androgenetic alopecia (AGA).

The document suggests using trazodone and clomiphene to treat sexual dysfunction caused by post-finasteride syndrome.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.